Inter-relationship between tumour necrosis

Armstrong, Lynne; Foley, Noeleen M.; Millar, Ann B.
June 1999
Thorax;Jun1999, p524
Academic Journal
No abstract available.


Related Articles

  • The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Dutta, S; Going, J J; Crumley, A B C; Mohammed, Z; Orange, C; Edwards, J; Fullarton, G M; Horgan, P G; McMillan, D C // British Journal of Cancer;2/14/2012, Vol. 106 Issue 4, p702 

    Background:There is increasing evidence that the local and systemic inflammatory responses are associated with survival in oesophageal cancer. The aim of this study was to examine the relationship between tumour necrosis, tumour proliferation, local and systemic inflammation and microvessel...

  • The polymorphism -863C/A in tumour necrosis factor-α gene contributes an independent association to gout. Chang, S.-J.; Tsai, P.-C.; Chen, C.-J.; Lai, H.-M.; Ko, Y.-C. // Rheumatology;Nov2007, Vol. 46 Issue 11, p1662 

    Objective. To investigate the associations between polymorphisms in the promoter of the tumour necrosis factor-α (TNF-α) gene and gout.

  • Diffusion weighted imaging in radiation necrosis. Biousse, V.; Newman, N. J.; Hunter, S. B.; Hudgins, P. A. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2003, Vol. 74 Issue 3, p382 

    This case report suggests that magnetic resonance imaging with diffusion weighted imaging may help distinguish between tumour recurrence and radiation induced necrosis in patients previously treated for a brain tumour.

  • Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Guthrie, G J K; Roxburgh, C S D; Richards, C H; Horgan, P G; McMillan, D C // British Journal of Cancer;7/9/2013, Vol. 109 Issue 1, p131 

    Background:Cancer-associated inflammation, in the form of local and systemic inflammatory responses, appear to be linked to tumour necrosis and have prognostic value in patients with colorectal cancer. However, their relationship with circulating biochemical mediators is unclear. The aim of the...

  • Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB. Taoufik, Era; Tseveleki, Vivian; Chu, Seung Y.; Tselios, Theodore; Karin, Michael; Lassmann, Hans; Szymkowski, David E.; Probert, Lesley // Brain: A Journal of Neurology;Sep2011, Vol. 134 Issue 9, p2722 

    Tumour necrosis factor mediates chronic inflammatory pathologies including those affecting the central nervous system, but non-selective tumour necrosis factor inhibitors exacerbate multiple sclerosis. In addition, TNF receptor SF1A, which encodes one of the tumour necrosis factor receptors, has...

  • Tumour necrosis factor and cancer. Balkwill, Frances // Nature Reviews Cancer;May2009, Vol. 9 Issue 5, p361 

    Tumour necrosis factor (TNF) is a major inflammatory cytokine that was first identified for its ability to induce rapid haemorrhagic necrosis of experimental cancers. When efforts to harness this anti-tumour activity in cancer treatments were underway, a paradoxical tumour-promoting role of TNF...

  • Anti-TNF-α therapy for uveitis: Behçet and beyond. Murray, P. I.; Sivaraj, R. R. // Eye;Aug2005, Vol. 19 Issue 8, p831 

    Focuses on the use of anti-Tumour Necrosis Factor-α therapy for refractory posterior uveitis. Role of tumour necrosis factor in the pathogenesis of inflammation; Success of anti-Tumour Necrosis Factor-α therapies in modulating other autoimmune diseases; Administration for the anti-Tumour...

  • Cell death: At the crossroads of cell death pathways. Zlotorynski, Eytan // Nature Reviews Molecular Cell Biology;Apr2014, Vol. 15 Issue 4, p222 

    The article presents information on a study on crossroads of cell death pathways between tumour necrosis factor (TNF) and receptor-interacting protein kinase 3 (RIPK3)-dependent necroptosis.

  • Possible relationship between golimumab and meningitis.  // Reactions Weekly;Feb2014, Vol. 1488 Issue 1, p2 

    The article focuses on the report published in the "WHO Pharmaceuticals Newsletter" which discusses the possible causal relationship between anti-tumour necrosis factor (TNF) drug golimumab and meningitis.

  • Efficacy of Loco-Regional Ablation Therapy of HCC in a Population of Liver Transplanted Patients. Rosa Stigliano; Andrew Godfrey; Gioacchino Leandro; David Patch; Brian Davidson; Keith Rolles; Arjun Dhillon; Amar Dhillon; Alberto Quaglia; Andrew Burroughs // Digestive Diseases & Sciences;Apr2008, Vol. 53 Issue 4, p1131 

    Abstract   Background and objective Loco-ablation therapy (LAT) has become standard treatment for patients with HCC who are candidates for liver transplantation (LT). The aim of this study was: to evaluate if LAT was able to induce complete necrosis of tumour mass; to determine...


Read the Article


Sign out of this library

Other Topics